Are you Dr. Bedikian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 65 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161- Is this information wrong?
Summary
- Dr. Agop Bedikian, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with University of Texas M.D. Anderson Cancer Center.
Education & Training
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1975 - 1977
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1974 - 1975
St Louis Connect CareInternship, Internal Medicine, 1972 - 1973
American University of Beirut Faculty of MedicineClass of 1971
Certifications & Licensure
TX State Medical License 1976 - 2020
Clinical Trials
- Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma Start of enrollment: 1995 Nov 01
- Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy Start of enrollment: 2004 Dec 01
- Taxoprexin® Treatment for Advanced Eye Melanoma Start of enrollment: 2005 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 25 citationsAdjuvant Ipilimumab in High-Risk Uveal MelanomaEric Fountain, Roland L. Bassett, Suzanne Cain, Liberty Posada, Dan S. Gombos, Patrick Hwu, Agop Y. Bedikian, Sapna Pradyuman Patel> ;Cancers. 2019 Jan 29
- 2 citationsPhase I/II study of hepatic arterial infusion of nab-paclitaxel in patients with metastatic melanoma to the liverJesus Vera-Aguilera, Agop Y. Bedikian, Roland L. Bassett, Wen-Jen Hwu, Kevin B. Kim, Yong Qin, Suzanne Cain, Edwina Washington, Michael A. Davies, Sunil M. Patel, Jade...> ;American Journal of Clinical Oncology. 2018 Nov 1
- 23 citationsA phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma.Sapna Pradyuman Patel, Dae Won Kim, Roland L. Bassett, Suzanne Cain, Edwina Washington, Wen-Jen Hwu, Kevin B. Kim, Nicholas E. Papadopoulos, Jade Homsi, Patrick Hwu, A...> ;Cancer Immunology, Immunotherapy. 2017 Jun 13
- Join now to see all
Press Mentions
MD Anderson Saved My Life — and My Adolescent Daughter’sAugust 21st, 2019
Professional Memberships
- Member
Hospital Affiliations
University of Texas M.D. Anderson Cancer CenterHouston, Texas
